1-1 of 1
Hans-Jurgen Mager
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Randomized, Placebo-Controlled, Multicenter Proof-of-Concept (POC) Study to Assess the Safety and Efficacy of the Novel Allosteric AKT Inhibitor, VAD044, in Adults with Hereditary Hemorrhagic Telangiectasia (HHT)

Hanny Al-Samkari, Josefien Hessels, Antoni Riera-Mestre, Sophie Dupuis-Girod, Thibaut Van Zele, Vincente Gómez del Olmo, Pierre Saint-Mezard, Hedvika Lazar, Damien Picard, Debra Barker, Elisabetta Buscarini, Hans-Jurgen Mager
Journal: Blood
Blood (2024) 144 (Supplement 1): 553.
https://doi.org/10.1182/blood-2024-206244
Published: 2024